Primary Job Title Scientific Founder, Chief Technology Officer, Advisor Primary Organization RayzeBio
Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Female
LinkedIn View on LinkedIn
Deborah is the scientific Founder, Chief Technology Officer, Advisor of RayzeBio, Inc. Prior to RayzeBio, Deborah held a number of scientific leadership positions in biotech, focused on translational drug development. At Nektar Therapeutics, she conceived of and led the pre-clinical and early clinical development of an Immuno-Oncology pipeline,
starting with NKTR-214, a next-generation IL-2 receptor agonist, currently in several pivotal Phase 3 oncology trials and later an IL-15 receptor agonist and TLR 7/8 agonist. At FivePrime Therapeutics, Deborah led a team that contributed to the clinical development of novel biologics for pan-FGF and CSF1 inhibition for oncology. While at Chiron Corporation she initiated and led a large proteomics effort to guide oncology target discovery, including the discovery of peptide-mimetic binders (‘peptoids’). At Lawrence Berkeley National Laboratory, she assumed an academic leadership role as a tenured Principal Investigator, focusing on new biomaterials. Deborah’s formal education is in Chemistry, earning a Ph.D. from the University of California at Berkeley and a B.S. in Chemistry from Carnegie-Mellon University, Pittsburgh, PA where she also learned to fly small airplanes.
